BUZZ-2026 年收入预期高于预期，铁木真制药公司业绩大涨

路透中文

Jan 02

1月2日 - ** 制药商Ironwood Pharmaceuticals IRWD.O股价盘前上涨20.2%至4.05美元

** 根据LSEG汇编的数据，IRWD预计2026年的年收入将在4.5亿至4.7亿美元之间，而分析师预计为3.194亿美元。

** 预计2026年便秘药物Linzess在美国的净销售额在11.3亿美元和11.8亿美元之间，主要受净价格上涨和低个位数百分比需求增长的推动 - IRWD

** 维持 2025 年收入在 2.9 亿至 3.1 亿美元之间的预测，而预期收入为 3.071 亿美元。

** 在过去 12 个月中，股价下跌了 23.9

(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2600063508"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2600063508\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2600063508?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-01-02 20:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2600063508","market":"us","top_or_hot":-1,"title":"BUZZ-2026 年收入预期高于预期，铁木真制药公司业绩大涨","media":"路透中文","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-2026 年收入预期高于预期，铁木真制药公司业绩大涨</title></head><body><p><span>1月2日</span><span> - </span>** 制药商Ironwood Pharmaceuticals <span>IRWD.O</span>股价盘前上涨20.2%至4.05美元</p><p>** 根据LSEG汇编的数据，IRWD预计2026年的年收入将在4.5亿至4.7亿美元之间，而分析师预计为3.194亿美元。 </p><p>** 预计2026年便秘药物Linzess在美国的净销售额在11.3亿美元和11.8亿美元之间，主要受净价格上涨和低个位数百分比需求增长的推动 - IRWD</p><p>** 维持 2025 年收入在 2.9 亿至 3.1 亿美元之间的预测，而预期收入为 3.071 亿美元。</p><p>** 在过去 12 个月中，股价下跌了 23.9</p><p>(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-2026 年收入预期高于预期，铁木真制药公司业绩大涨</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-2026 年收入预期高于预期，铁木真制药公司业绩大涨\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1098195322\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">路透中文 </p>\n<p class=\"h-time\">2026-01-02 20:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-2026 年收入预期高于预期，铁木真制药公司业绩大涨</title></head><body><p><span>1月2日</span><span> - </span>** 制药商Ironwood Pharmaceuticals <span>IRWD.O</span>股价盘前上涨20.2%至4.05美元</p><p>** 根据LSEG汇编的数据，IRWD预计2026年的年收入将在4.5亿至4.7亿美元之间，而分析师预计为3.194亿美元。 </p><p>** 预计2026年便秘药物Linzess在美国的净销售额在11.3亿美元和11.8亿美元之间，主要受净价格上涨和低个位数百分比需求增长的推动 - IRWD</p><p>** 维持 2025 年收入在 2.9 亿至 3.1 亿美元之间的预测，而预期收入为 3.071 亿美元。</p><p>** 在过去 12 个月中，股价下跌了 23.9</p><p>(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260102:nL4S3Y30DY:1","article_id":"2600063508","we_media_id":"1098195322","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2600063508","pubTimestamp":1767357021,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"路透中文","introduction":"路透中文","home_visible":1,"id":"1098195322","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-2026 年收入预期高于预期，铁木真制药公司业绩大涨1月2日 - ** 制药商Ironwood Pharmaceuticals IRWD.O股价盘前上涨20.2%至4.05美元** 根据LSEG汇编的数据，IRWD预计2026年的年收入将在4.5亿至4.7亿美元之间，而分析师预计为3.194亿美元。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","IRWD":"Ironwood医药"},"translate_title":"BUZZ-2026 Revenue Estimates Above Estimates, Temujin Pharmaceuticals' Results Surge","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IRWD":0.9},"content_text":"BUZZ-2026 年收入预期高于预期，铁木真制药公司业绩大涨1月2日 - ** 制药商Ironwood Pharmaceuticals IRWD.O股价盘前上涨20.2%至4.05美元** 根据LSEG汇编的数据，IRWD预计2026年的年收入将在4.5亿至4.7亿美元之间，而分析师预计为3.194亿美元。 ** 预计2026年便秘药物Linzess在美国的净销售额在11.3亿美元和11.8亿美元之间，主要受净价格上涨和低个位数百分比需求增长的推动 - IRWD** 维持 2025 年收入在 2.9 亿至 3.1 亿美元之间的预测，而预期收入为 3.071 亿美元。** 在过去 12 个月中，股价下跌了 23.9(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":true,"code":"91000000","status":"200"}}}